->

Ukuvivinya umzimba njalo kunciphisa ubungozi bezinhlobo ezi-7 zomdlavuza

Ukuzivocavoca njalo kunciphisa ubungozi bezinhlobo eziyisi-7 ezahlukene zomdlavuza kutholwe ocwaningweni olwenziwa umphakathi womdlavuza waseMelika, I-National Cancer Institute & Harvard THChan School of public health.

Yabelana ngalokhu okuthunyelwe

Ucwaningo olwenziwa e-US lwathola ukuthi ukuzivocavoca njalo kunciphisa ubungozi bezinhlobo eziyisi-7 zomdlavuza. Lolu cwaningo lwenziwe ngabakwa I-American Cancer Society, Isikhungo Somdlavuza Kazwelonke, & IHarvard T.han School yezempilo yomphakathi. Lolu cwaningo lushicilelwe ku-Journal of Clinical Oncology.

Inhloso yocwaningo

Ukunquma ukuthi inani elinconywayo lomsebenzi wokuzilibazisa wesikhathi sokuzilibazisa (isb., Amahora ayi-7.5-15 we-metabolic task [MET] amahora / ngesonto) lihambisana nobungozi bomdlavuza ophansi, chaza ukuma kobudlelwano bokuphendula ngomthamo, futhi uhlole izinhlangano ezinokulinganisela- nokusebenza ngamandla ngokomzimba.

Umphumela wesifundo

Ingqikithi yabahlanganyeli abangama-755,459 (ubudala obuphakathi, iminyaka engama-62 [ibanga, iminyaka engama-32-91]; ama-53% abesifazane) alandelwe iminyaka eyi-10.1, kwathi umdlavuza wezehlakalo ezingama-50,620 wanda. Ukuzibandakanya kumanani omsebenzi anconyiwe (amahora we-7.5-15 MET / ngesonto) kuhlotshaniswa nengozi ephansi ngokwezibalo yezinhlobo zomdlavuza ezi-7 kwezingu-15 ezifundiwe, kufaka phakathi ikholoni (8% -14% engcupheni ephansi emadodeni), ibele (6% -10% ingozi ephansi), i-endometrial (10% -18% ingozi ephansi), izinso (11% -17% ingozi ephansi), i-myeloma (14% -19% engcupheni ephansi), isibindi (18% -27% ingozi ephansi) , kanye ne-Non-Hodgkin lymphoma (11% -18% engcupheni ephansi kwabesifazane). Impendulo yedosi yayimile ngokulingana ngengxenye yenhlangano kanye nonlinear kwabanye. Imiphumela yomsebenzi wokuzilibazisa wesikhathi esilinganiselayo namandla Ukulungiswa kwenkomba yesisindo somzimba kuqede ukuhlangana nomdlavuza we-endometrial kepha kwaba nomphumela olinganiselwe kwezinye izinhlobo zomdlavuza.
Ukuvivinya umzimba njalo kwakuxhunyaniswe ngokukhethekile ne:

  • Ingcuphe ephansi engu-8% yomdlavuza wekoloni emadodeni amahora angama-7.5 MET ngeviki kanye ne-14% engcupheni ephansi yamahora we-15 MET ngesonto
  • Ingozi ephansi ngo-6% yomdlavuza webele kwabesifazane ngamahora we-7.5 MET ngeviki kanye ne-10% engcupheni ephansi yamahora we-15 MET ngesonto
  • Ingozi ephansi ka-10% yomdlavuza we-endometrium kwabesifazane ngamahora we-7.5 MET ngeviki kanye ne-18% engcupheni ephansi yamahora we-15 MET ngesonto
  • Ingozi ephansi engu-11% yomdlavuza wezinso amahora angama-7.5 MET ngeviki kanye ne-17% engcupheni ephansi yamahora we-15 MET ngesonto
  • Ingozi ephansi engu-14% ye-myeloma eminingi yamahora we-7.5 MET ngeviki kanye ne-19% engcupheni ephansi yamahora we-15 MET ngesonto
  • Ingozi ephansi engu-18% yomdlavuza wesibindi yamahora we-7.5 MET ngeviki kanye ne-27% engcupheni ephansi yamahora we-15 MET ngesonto
  • Ingozi ephansi engu-11% ye-Non-Hodgkin lymphoma kwabesifazane amahora angu-7.5 MET ngesonto kanye nobungozi obuphansi obungu-18% bamahora we-15 MET ngesonto

Ngakho-ke kuliqiniso ukuthi ukuzivocavoca umzimba njalo kuyisikhali esinamandla kakhulu sokuvikela umdlavuza. Izinhlobo zomdlavuza eziqinisekisiwe ezingavinjelwa umdlavuza weColon, umdlavuza webele, umdlavuza we-Endometrial, umdlavuza wezinso, iMultiple Myeloma, umdlavuza wesibindi, iMyeloma, i-Non-Hodgkin Lymphoma.
Ukuhamba imizuzu engama-30 ngosuku kunciphisa kakhulu lezi zingozi.

Bhalisa ku-Newsletter yethu

Thola izibuyekezo futhi ungalokothi uphuthelwe ibhulogi evela kuCancerfax

Okuningi Okuzohlolwa

Ukuqonda I-Cytokine Release Syndrome: Izimbangela, Izimpawu, Nokwelashwa
Ukwelashwa kwe-CAR T-Cell

Ukuqonda I-Cytokine Release Syndrome: Izimbangela, Izimpawu, Nokwelashwa

I-Cytokine Release Syndrome (CRS) iwukusabela kwamasosha omzimba okuvame ukubangelwa izindlela zokwelapha ezithile ezifana ne-immunotherapy noma i-CAR-T cell therapy. Kuhilela ukukhululwa ngokweqile kwama-cytokines, okubangela izimpawu ezisukela kumkhuhlane nokukhathala kuya ezinkingeni ezingase zibeke ukuphila engozini njengokulimala kwesitho. Ukuphatha kudinga ukuqapha ngokucophelela kanye namasu okungenelela.

Alysha Mendossa April 29, 2024
Iqhaza labezimo eziphuthumayo empumelelweni yokwelashwa kwe-CAR T Cell
Ukwelashwa kwe-CAR T-Cell

Iqhaza labezimo eziphuthumayo empumelelweni yokwelashwa kwe-CAR T Cell

Abezimo eziphuthumayo badlala indima ebalulekile empumelelweni yokwelashwa kwe-CAR T-cell ngokuqinisekisa ukunakekelwa kwesiguli okungenamthungo kuyo yonke inqubo yokwelashwa. Banikeza ukwesekwa okubalulekile ngesikhathi sokuthutha, ukuqapha izimpawu ezibalulekile zeziguli, nokuphatha ukungenelela kwezokwelapha eziphuthumayo uma izinkinga ziphakama. Ukusabela kwabo okusheshayo kanye nokunakekelwa kochwepheshe kunomthelela ekuphepheni okuphelele nasekusebenzeni ngempumelelo kokwelashwa, kusiza uguquko olushelelayo phakathi kwezilungiselelo zokunakekelwa kwezempilo kanye nokwenza ngcono imiphumela yesiguli endaweni eyinselele yezindlela zokwelapha ezithuthukisiwe zamaselula.

Susan Hau April 29, 2024

Dinga usizo? Ithimba lethu likulungele ukukusiza.

Sifisela ukululama okusheshayo kothandekayo wakho futhi oseduze.

Xhumana nathi
Qala ingxoxo
Siku-inthanethi! Xoxa Nathi!
Skena ikhodi
Sawubona,

Siyakwamukela kuCancerFax!

ICancerFax iyinkundla yokuphayona ezinikele ekuxhumaniseni abantu ababhekene nomdlavuza oseqophelweni eliphezulu ngemithi yokwelapha yamangqamuzana efana ne-CAR T-Cell therapy, ukwelashwa kwe-TIL, nezivivinyo zomtholampilo emhlabeni wonke.

Sazise ukuthi yini esingakwenzela yona.

1) Ukwelashwa komdlavuza phesheya?
2) Ukwelashwa kwe-CAR T-Cell
3) Umuthi wokugomela umdlavuza
4) Ukubonisana ngevidiyo eku-inthanethi
5) Ukwelashwa kweProton